blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2044063

EP2044063 - PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.05.2012
Database last updated on 11.09.2024
Most recent event   Tooltip25.05.2012Application deemed to be withdrawnpublished on 27.06.2012  [2012/26]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[N/P]
Former [2009/15]For all designated states
Astra Zeneca AB
151 85 Södertälje / SE
Inventor(s)01 / BUTTAR, David
AstraZeneca R & D Alderley Alderley Park Macclesfield
Cheshire SK10 4TG / GB
02 / FOOTE, Kevin, Michael
AstraZeneca R & D Alderley Alderley Park Macclesfield
Cheshire SK10 4TG / GB
03 / NOWAK, Thorsten
AstraZeneca R & D Alderley Alderley Park Macclesfield
Cheshire SK10 4TG / GB
04 / RUDGE, David, Alan
AstraZeneca R & D Alderley Alderley Park Macclesfield
Cheshire SK10 4TG / GB
05 / THEOCLITOU, Maria-Elena
AstraZeneca R & D Alderley Alderley Park Macclesfield
Cheshire SK10 4TG / GB
06 / THOMAS, Andrew, Peter
AstraZeneca R & D Alderley Alderley Park Macclesfield
Cheshire SK10 4TG / GB
 [2009/15]
Application number, filing date07733374.827.06.2007
[2009/15]
WO2007GB02381
Priority number, dateUS20060818259P30.06.2006         Original published format: US 818259 P
US20070908428P28.03.2007         Original published format: US 908428 P
[2009/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008001070
Date:03.01.2008
Language:EN
[2008/01]
Type: A1 Application with search report 
No.:EP2044063
Date:08.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2008 takes the place of the publication of the European patent application.
[2009/15]
Search report(s)International search report - published on:EP03.01.2008
ClassificationIPC:C07D413/14, A61K31/506, A61P35/00
[2009/15]
CPC:
C07D413/14 (EP,KR,US); A61K31/506 (KR); A61P35/00 (EP);
A61P43/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/15]
Extension statesALNot yet paid
BANot yet paid
HR30.01.2009
MKNot yet paid
RSNot yet paid
TitleGerman:FÜR DIE BEHANDLUNG VON KREBS GEEIGNETE PYRIMIDINDERIVATE[2009/15]
English:PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER[2009/15]
French:DÉRIVÉS DE PYRIMIDINE UTILES DANS LE TRAITEMENT DU CANCER[2009/15]
Entry into regional phase30.01.2009National basic fee paid 
30.01.2009Designation fee(s) paid 
30.01.2009Examination fee paid 
Examination procedure08.01.2009Amendment by applicant (claims and/or description)
30.01.2009Examination requested  [2009/15]
03.01.2012Application deemed to be withdrawn, date of legal effect  [2012/26]
07.02.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/26]
Fees paidRenewal fee
30.06.2009Renewal fee patent year 03
30.06.2010Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.201105   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO03048133  (ASTRAZENECA AB [SE], et al) [Y] 1-49 * the whole document *;
 [Y]WO2005040159  (ASTRAZENECA AB [SE], et al) [Y] 1-49 * page 39 *;
 [Y]WO2005049033  (ASTRAZENECA AB [SE], et al) [Y] 1-49 * the whole document *;
 [PX]WO2006074057  (EXELIXIS INC [US], et al) [PX] 1-49* example - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.